Sanofi Touts Late Stage Antidepressants’ Tolerability As Key For Combo Use
Sanofi-Aventis is positioning its two late-stage antidepressant candidates as potential components of combination regimens
Sanofi-Aventis is positioning its two late-stage antidepressant candidates as potential components of combination regimens